First-in-Human Dose Escalation Trial of ATRC-101 in Adults With Advanced Solid Malignancies
Conditions: Breast Cancer; Colorectal Cancer; Ovarian Cancer; Non Small Cell Lung Cancer; Acral Lentiginous Melanoma Intervention: Biological: ATRC-101 Sponsor: Atreca, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials